United States Pharmacopeia

Last updated
United States Pharmacopeia
Type Nonprofit
Founded1820;203 years ago (1820)
Headquarters,
United States
Key people
Ronald T. Piervincenzi (CEO) [1]
Website www.usp.org

The United States Pharmacopeia (USP) is a pharmacopeia (compendium of drug information) for the United States published annually by the over 200-year old United States Pharmacopeial Convention (usually also called the USP), a nonprofit organization that owns the trademark and also owns the copyright on the pharmacopeia itself.

Contents

The USP is published in a combined volume with the National Formulary (a formulary) as the USP-NF. [2] If a drug ingredient or drug product has an applicable USP quality standard (in the form of a USP-NF monograph), it must conform in order to use the designation "USP" or "NF". Drugs subject to USP standards include both human drugs (prescription, over-the-counter, or otherwise) and animal drugs. USP-NF standards also have a role in US federal law; a drug or drug ingredient with a name recognized in USP-NF is considered adulterated if it does not satisfy compendial standards for strength, quality, or purity. USP also sets standards for dietary supplements and food ingredients (as part of the Food Chemicals Codex ). USP has no role in enforcing its standards; enforcement is the responsibility of the U.S. Food and Drug Administration (FDA) and other government authorities in the United States.[ vague ][ citation needed ]

History of the United States Pharmacopeia Organization

The U.S. Pharmacopeia (USP) was formed in 1820 when 11 physicians came together to take action to protect patients from being harmed by the inconsistent and poor-quality medical preparations at that time. The first standards were "recipes" that guided the preparation of medicines, which were often manufactured in apothecaries relying heavily on crude botanical drugs having therapeutic activities. [3] When the modern pharmaceutical industry emerged, USP standards changed from those "recipes" to a set of quality specifications for medicines along with analytical tests to be performed to assess their purity, quality, and authenticity. [3]

Product quality–standards and verification

USP establishes documentary (written) and reference (physical) standards for medicines, food ingredients, dietary supplement products, and ingredients. These standards are used by regulatory agencies and manufacturers to help to ensure that these products are of the appropriate identity, as well as strength, quality, purity, and consistency. USP 800 is an example of a publication created by the United States Pharmacopeia.

Prescription and over-the-counter medicines available in the United States must, by federal law, meet USP-NF public standards, where such standards exist. Many other countries use the USP-NF instead of issuing their own pharmacopeia, or to supplement their government pharmacopeia.

USP's standards for food ingredients can be found in its Food Chemicals Codex (FCC). The FCC is a compendium of standards used internationally for the quality and purity of food ingredients like preservatives, flavorings, colorings, and nutrients. While the FCC is recognized in law in countries like Australia, Canada, and New Zealand, it currently does not have statutory recognition in the United States, although FCC standards are incorporated by reference in over 200 FDA food regulations. [4] USP obtained the FCC from the Institute of Medicine in 2006. The IOM had published the first five editions of the FCC.

USP also conducts verification programs for dietary supplement products and ingredients. These are testing and audit programs. Products that meet the requirements of the program can display the USP Verified Dietary Supplement Mark on their labels. [5] This is different from seeing the letters "USP" alone on a dietary supplement label, which means that the manufacturer is claiming to adhere to USP standards. USP does not test such products as it does with USP Verified products.

Healthcare information

In the past, Congress authorized the Secretary of HHS to request USP to develop a drug classification system that Medicare Prescription Drug Benefit plans may use to develop their formularies, [6] and to revise such classification from time to time to reflect changes in therapeutic uses covered by Part D drugs and the addition of new covered Part D drugs. USP has developed six versions of the Model Guidelines, the last issued early in 2014 for the 2015–2017 benefit years. [7]

Promoting the Quality of Medicines program

Since 1992, USP has worked cooperatively with the United States Agency for International Development (USAID) to help developing countries address critical issues related to poor quality medicines. This partnership operated as the Drug Quality and Information (DQI) program until 2009, when, to better meet growing global needs, USAID awarded USP a five-year, $35 million cooperative agreement to establish a new, expanded program called Promoting the Quality of Medicines (PQM). [8] [9] In 2013 USAID extended the PQM program for five years (through September 2019), increased its funding to $110 million, and expanded the geographical reach of the program. [10]

PQM serves as a primary mechanism to help USAID-supported countries strengthen their quality assurance and quality control systems to better ensure the quality of medicines that reach patients. PQM has four key objectives: [11]

USP-USAID collaborative efforts have helped communities improve drug quality in more than 35 countries. PQM currently works in Africa, [12] Asia, [13] Europe/Eurasia, [14] and the Caribbean/Latin America. [15]

International agreements and offices

USP works internationally, largely through agreements with other pharmacopeias, as well as regulatory bodies, manufacturer associations, and others. In recent years, USP signed a series of Memoranda of Understanding (MOU) with groups including the Pharmacopeia of the People's Republic of China Chinese Pharmacopeia Commission, nine countries belonging to the Association of Southeast Asian Nations (ASEAN), and the Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor). [16] USP also operates an international office in Switzerland and offices and laboratories in Brazil, India, and China.

See also

Related Research Articles

<span class="mw-page-title-main">Pure Food and Drug Act</span> 1906 consumer protection law in the US

The Pure Food and Drug Act of 1906, also known as Dr. Wiley's Law, was the first of a series of significant consumer protection laws which was enacted by Congress in the 20th century and led to the creation of the Food and Drug Administration. Its main purpose was to ban foreign and interstate traffic in adulterated or mislabeled food and drug products, and it directed the U.S. Bureau of Chemistry to inspect products and refer offenders to prosecutors. It required that active ingredients be placed on the label of a drug's packaging and that drugs could not fall below purity levels established by the United States Pharmacopeia or the National Formulary.

<span class="mw-page-title-main">Dietary supplement</span> Product that provides additional source of nutrients

A dietary supplement is a manufactured product intended to supplement one's diet by taking a pill, capsule, tablet, powder, or liquid. A supplement can provide nutrients either extracted from food sources or that are synthetic in order to increase the quantity of their consumption. The class of nutrient compounds includes vitamins, minerals, fiber, fatty acids, and amino acids. Dietary supplements can also contain substances that have not been confirmed as being essential to life, but are marketed as having a beneficial biological effect, such as plant pigments or polyphenols. Animals can also be a source of supplement ingredients, such as collagen from chickens or fish for example. These are also sold individually and in combination, and may be combined with nutrient ingredients. The European Commission has also established harmonized rules to help insure that food supplements are safe and appropriately labeled.

<span class="mw-page-title-main">Rubbing alcohol</span> Alcohol used for germ protection

Rubbing alcohol is either an isopropyl alcohol or an ethanol-based liquid, with isopropyl alcohol products being the most widely available. The comparable British Pharmacopoeia (BP) is surgical spirit. Rubbing alcohol is denatured and undrinkable even if it is ethanol-based, due to the bitterants added.

<span class="mw-page-title-main">Pharmacopoeia</span> Book containing directions for the identification of compound medicines

A pharmacopoeia, pharmacopeia, or pharmacopoea, in its modern technical sense, is a book containing directions for the identification of compound medicines, and published by the authority of a government or a medical or pharmaceutical society.

<span class="mw-page-title-main">Sodium benzoate</span> Chemical compound

Sodium benzoate also known as benzoate of soda is the sodium salt of benzoic acid, widely used as a food preservative (with an E number of E211) and a pickling agent. It appears as a white crystalline chemical with the formula C6H5COONa.

The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

Emulsifying wax is a cosmetic emulsifying ingredient. The ingredient name is often followed by the initials NF, indicating that it conforms to the specifications of the National Formulary.

<span class="mw-page-title-main">Pill splitting</span>

Pill-splitting refers to the practice of splitting a tablet or pill to provide a lower dose of the active ingredient, or to obtain multiple smaller doses, either to reduce cost or because the pills available provide a larger dose than required. Many pills that are suitable for splitting come pre-scored so that they may easily be halved.

<i>European Pharmacopoeia</i> Major multinational pharmacopoeia published by the European Union

The European Pharmacopoeia is a major regional pharmacopoeia which provides common quality standards throughout the pharmaceutical industry in Europe to control the quality of medicines, and the substances used to manufacture them. It is a published collection of monographs which describe both the individual and general quality standards for ingredients, dosage forms, and methods of analysis for medicines. These standards apply to medicines for both human and veterinary use.

<span class="mw-page-title-main">Compounding</span> Preparation of a custom medication

In the field of pharmacy, compounding is preparation of a custom medication to fit a unique need of a patient that cannot be met with commercially available products. This may be done for medical reasons, such as administration in a different format, to avoid a non-active ingredient the patient is allergic to, or to provide an exact dose that isn't commercially available. Patient-specific compounding according to a prescriber's specifications is referred to as "traditional" compounding. The nature of patient need for such customization can range from absolute necessity to individual optimality to even preference.

Chinese patent medicine are herbal medicines in Traditional Chinese medicine, modernized into a ready-to-use form such as tablets, oral solutions or dry suspensions, as opposed to herbs that require cooking.

The Center for Food Safety and Applied Nutrition is the branch of the United States Food and Drug Administration (FDA) that regulates food, dietary supplements, and cosmetics, as opposed to drugs, biologics, medical devices, and radiological products, which also fall under the purview of the FDA.

<span class="mw-page-title-main">European Directorate for the Quality of Medicines & HealthCare</span> International organisation

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a Directorate of the Council of Europe that traces its origins and statutes to the Convention on the Elaboration of a European Pharmacopoeia.

In the pharmaceutical industry, drug dissolution testing is routinely used to provide critical in vitro drug release information for both quality control purposes, i.e., to assess batch-to-batch consistency of solid oral dosage forms such as tablets, and drug development, i.e., to predict in vivo drug release profiles. There are three typical situations where dissolution testing plays a vital role: (i) formulation and optimization decisions: during product development, for products where dissolution performance is a critical quality attribute, both the product formulation and the manufacturing process are optimized based on achieving specific dissolution targets. (ii) Equivalence decisions: during generic product development, and also when implementing post-approval process or formulation changes, similarity of in vitro dissolution profiles between the reference product and its generic or modified version are one of the key requirements for regulatory approval decisions. (iii) Product compliance and release decisions: during routine manufacturing, dissolution outcomes are very often one of the criteria used to make product release decisions.

The Pharmacopoeia of the People's Republic of China (PPRC) or the Chinese Pharmacopoeia (ChP), compiled by the Pharmacopoeia Commission of the Ministry of Health of the People's Republic of China, is an official compendium of drugs, covering Traditional Chinese and western medicines, which includes information on the standards of purity, description, test, dosage, precaution, storage, and the strength for each drug.

A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication. Today, the main function of a prescription formulary is to specify particular medications that are approved to be prescribed at a particular hospital, in a particular health system, or under a particular health insurance policy. The development of prescription formularies is based on evaluations of efficacy, safety, and cost-effectiveness of drugs.

A drug reference standard or pharmaceutical reference standard is a highly characterized material suitable to test the identity, strength, quality and purity of substances for pharmaceutical use and medicinal products.

Drug nomenclature is the systematic naming of drugs, especially pharmaceutical drugs. In the majority of circumstances, drugs have 3 types of names: chemical names, the most important of which is the IUPAC name; generic or nonproprietary names, the most important of which are international nonproprietary names (INNs); and trade names, which are brand names. Under the INN system, generic names for drugs are constructed out of affixes and stems that classify the drugs into useful categories while keeping related names distinguishable. A marketed drug might also have a company code or compound code.

The Food Chemicals Codex (FCC) is a collection of internationally recognized standards for the purity and identity of food ingredients.

In chemistry, chemical purity is the measurement of the amount of impurities found in a sample. Several grades of purity are used by the scientific, pharmaceutical, and industrial communities. Some of the commonly used grades of purity include:

References

  1. U.S. Pharmacopeial Convention (2014-01-08), "Ron Piervincenzi, Ph.D., Named Next CEO Of USP", PR Newswire
  2. "National Formulary". MedicineNet. Retrieved 2015-12-11.
  3. 1 2 "U.S. Pharmacopeia: Building trust for 200 years". Archived from the original on 2023-05-18. Retrieved 2023-08-18.
  4. "Federal Register | Food Additive Regulations; Incorporation by Reference of the Food Chemicals Codex, 7th Edition". www.federalregister.gov. Retrieved 2015-12-11.
  5. "Are Dietary Supplements Dangerous? - Consumer Reports". www.consumerreports.org. Retrieved 2015-12-11.
  6. "United States Pharmacopeia (USP). Medicare Prescription Drug Benefit Model Guidelines Source Information". www.nlm.nih.gov. Retrieved 2015-12-11.
  7. webadmin. "Part D Model Guidelines Updated Far Too Infrequently". Managed Care Magazine Online. Retrieved 2015-12-11.
  8. "Promoting the Quality of Medicines (PQM)".
  9. "How to curb 'fake' food, drug products in Nigeria by PQM". www.ngrguardiannews.com. 6 August 2015. Retrieved 2015-12-11.
  10. "USAID extends USP's Promoting the Quality of Medicines (PQM) programme - Express Pharma Online". archivepharma.financialexpress.com. Retrieved 2015-12-11.
  11. "Promoting the Quality of Medicines (PQM)". www.usp.org. Retrieved 2015-12-11.
  12. "PQM Activities in Africa | U.S. Pharmacopeial Convention". United States Pharmacopoeia. Archived from the original on 2016-04-05.
  13. "PQM Accomplishments in Asia | U.S. Pharmacopeial Convention". United States Pharmacopoeia. Archived from the original on 2016-04-08.
  14. "PQM in Europe-Eurasia | U.S. Pharmacopeial Convention". United States Pharmacopoeia. Archived from the original on 2016-04-05.
  15. "PQM's Work in Latin America and the Caribbean | U.S. Pharmacopeial Convention". United States Pharmacopoeia. Archived from the original on 2016-04-05.
  16. Федеральная служба по надзору в сфере здравоохранения

39°03′48″N77°06′56″W / 39.063270°N 77.115574°W / 39.063270; -77.115574